"L’IRCCS Ospedale San Raffaele è una struttura clinica-scientifica-universitaria di rilievo internazionale e di alta specializzazione per diverse importanti patologie, riconosciuta nel 1972 “Istituto di Ricovero e Cura a Carattere Scientifico” (IRCCS). La tematica della Medicina Molecolare è sempre stata l’elemento caratterizzante di questa Istituzione che ha scelto di focalizzare verso la comprensione dei processi molecolari e le applicazioni mediche delle scoperte della biologia molecolare con lo scopo di sviluppare terapie innovative per le patologie del sistema nervoso centrale e periferico, dell’apparato cardiovascolare e del metabolismo, per le patologie tumorali, le malattie infettive e immunomediate, le malattie genetiche e rare."

During the past decade, Ospedale San Raffaele conducted 512 clinical trials. In the 10-year time frame, 512 clinical trials started and 138 clinical trials were completed, i.e. on average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 247 clinical trials started and 92 clinical trials were completed. i.e. 37.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Raffaele" #1 sponsor was "IRCCS San Raffaele" with 84 trials, followed by "Hoffmann-La Roche" with 28 trials sponsored, "Janssen Research & Development, LLC" with 27 trials sponsored, "Ospedale San Raffaele" with 23 trials sponsored and "Abbott Medical Devices" with 23 trials sponsored. Other sponsors include 514 different institutions and companies that sponsored additional 282 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Raffaele" #1 collaborator was "San Raffaele University Hospital, Italy" with 8 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "AbbVie" with 5 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator and "IRCCS San Raffaele" with 5 trials as a collaborator. Other collaborators include 426 different institutions and companies that were collaborators in the rest 345 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Raffaele" are "Chronic Lymphocytic Leukemia" (15 trials), "Breast Cancer" (14 trials), "Carcinoma, Non-Small-Cell Lung" (13 trials), "Coronary Artery Disease" (12 trials) and "HIV Infections" (12 trials). Many other conditions were trialed in "Ospedale San Raffaele" in a lesser frequency.

Most popular intervention types in "Ospedale San Raffaele" are "Drug" (386 trials), "Device" (111 trials), "Procedure" (80 trials), "Other" (73 trials) and "Biological" (37 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (76 trials), "Carboplatin" (16 trials), "Paclitaxel" (16 trials), "Rituximab" (16 trials) and "Gemcitabine" (15 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Raffaele" are 636 trials for "All" genders, 38 trials for "Female" genders and 25 trials for "Male" genders.

Currently, there are 279 active trials in "Ospedale San Raffaele". 4 are not yet recruiting, 157 are recruiting, 112 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 284 completed trials in Ospedale San Raffaele, 3 suspended trials, and 64 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Raffaele, 45 "Phase 1" clinical trials were conducted, 160 "Phase 2" clinical trials and 211 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 112 trials that are defined as “Not Applicable".

Ospedale San Raffaele has several departments that took part in Clinical trials: "Irccs Ospedale San Raffaele;Oncologia Medica" - 19 trials, "IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla" - 18 trials, "IRCCS S. Raffaele; Ginecologia Oncologica" - 3 trials, "Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona, 20" - 3 trials, "Ospedale San Raffaele- Cardiac" - 3 trials, "Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia" - 30 trials, "IRCCS Ospedale San Raffaele Centro di Ricerca Anestesia e Rianimazione" - 2 trials, "IRCCS San Raffaele Medical Oncology Unit" - 2 trials, "IRCCS Ospedale San Raffaele; U.O. di Neurologia" - 2 trials, "Department of Surgery - Liver Unit, Scientific Institute San Raffaele," - 2 trials